Matsuda Katherine C, Hall Colin, Baker-Lee Cassandra, Soto Marcus, Scott George, Prince Peter J, Retter Marc W
Pharmacokinetics & Drug Metabolism (PKDM), Amgen, Inc., 1201 Amgen Court West, Seattle, WA 98119, USA.
Bioanalysis. 2013 Aug;5(16):1979-90. doi: 10.4155/bio.13.148.
Development of an alternative sampling method that uses small amounts of whole blood, such as dried blood spots (DBS), would be an advance in the quantitative assay field. Previously, we assessed the ability to quantitate therapeutic monoclonal antibodies present in DBS compared with a typical serum sample-based method, and concluded that measurements in DBS were reproducible and yielded methods that met requirements for precision, accuracy and sensitivity. The goal herein was to assess the measurement of therapeutic antibodies in DBS compared with serum and plasma in vivo.
Comparison of DBS versus serum in Sprague-Dawley rats and DBS versus plasma in cynomolgus monkeys for measurement of antibody concentrations revealed a two- to three-fold difference in exposure between the samples.
Overall, there was good correlation between DBS versus serum and DBS versus plasma, but there was a discrepancy in DBS exposures, presumably attributable to hematocrit and recovery effects.
开发一种使用少量全血的替代采样方法,如干血斑(DBS),将是定量分析领域的一项进展。此前,我们评估了与基于典型血清样本的方法相比,定量检测DBS中治疗性单克隆抗体的能力,并得出结论,DBS中的测量结果具有可重复性,且产生的方法符合精密度、准确度和灵敏度的要求。本文的目的是评估在体内将DBS中的治疗性抗体与血清和血浆进行比较测量的情况。
在测量抗体浓度时,将Sprague-Dawley大鼠的DBS与血清以及食蟹猴的DBS与血浆进行比较,结果显示样本之间的暴露量存在两到三倍的差异。
总体而言,DBS与血清以及DBS与血浆之间具有良好的相关性,但DBS的暴露量存在差异,推测这归因于血细胞比容和回收率的影响。